Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGuardian Pharmacy Services, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | $0.22 | $0.22 | $0.22 |
| Q2 2025 | 2 | $0.18 | $0.20 | $0.19 |
| Q3 2025 | 3 | $0.23 | $0.24 | $0.24 |
| Q4 2025 | 3 | $0.26 | $0.28 | $0.27 |
| Q1 2026 | 3 | $0.23 | $0.25 | $0.24 |
| Q2 2026 | 1 | $0.25 | $0.25 | $0.25 |
| Q3 2026 | 1 | $0.28 | $0.29 | $0.28 |
| Q4 2026 | 1 | $0.30 | $0.31 | $0.31 |
| Q1 2027 | 1 | $0.25 | $0.25 | $0.25 |
| Q2 2027 | 1 | $0.29 | $0.29 | $0.29 |
| Q3 2027 | 1 | $0.34 | $0.35 | $0.35 |
| Q4 2027 | 1 | $0.36 | $0.37 | $0.37 |
Guardian Pharmacy Services, Inc. Earnings Date And Information
Guardian Pharmacy Services, Inc. last posted its earnings results on Monday, November 10th, 2025. The company reported $0.25 earnings per share for the quarter, topping analysts' consensus estimates of $0.24 by $0.01. The company had revenue of 377.43 M for the quarter and had revenue of 1.23 B for the year. Guardian Pharmacy Services, Inc. has generated $-2 earnings per share over the last year ($-1.77 diluted earnings per share) and currently has a price-to-earnings ratio of 45.27. Guardian Pharmacy Services, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 10th, 2025 based on prior year's report dates.
Guardian Pharmacy Services, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/10/2025 | Q3 2025 | $0.24 | $0.16 | -0.08 | $354.15 M | $377.43 M |
| 08/11/2025 | Q2 2025 | $0.22 | $0.15 | -0.07 | $331.33 M | $344.33 M |
| 05/12/2025 | Q1 2025 | $0.22 | $0.15 | -0.07 | N/A | $329.31 M |
| 03/26/2025 | Q4 2024 | $0.21 | $0.20 | -0.01 | N/A | $338.57 M |
| 11/12/2024 | Q3 2024 | $0.19 | -$2.00 | -2.19 | $303.13 M | $314.39 M |
| 06/30/2024 | Q2 2024 | N/A | $0.17 | N/A | N/A | $300.04 M |
| 03/31/2024 | Q1 2024 | N/A | -$0.30 | N/A | N/A | $275.41 M |
| 12/31/2023 | Q4 2023 | N/A | $0.20 | N/A | N/A | $281.07 M |
| 09/30/2023 | Q3 2023 | N/A | -$0.19 | N/A | N/A | $262.74 M |
| 06/30/2023 | Q2 2023 | N/A | $0.35 | N/A | N/A | $253.44 M |
| 03/31/2023 | Q1 2023 | N/A | $0.03 | N/A | N/A | $248.95 M |
| 12/31/2022 | Q4 2022 | N/A | $0.00 | N/A | N/A | $236.89 M |
| 09/30/2022 | Q3 2022 | N/A | $0.00 | N/A | N/A | $236.89 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.10 | N/A | N/A | $224.08 M |
| 03/31/2022 | Q1 2022 | N/A | $0.30 | N/A | N/A | $211.05 M |
| 12/31/2021 | Q4 2021 | N/A | -$0.08 | N/A | N/A | $209.89 M |
| 09/30/2021 | Q3 2021 | N/A | $0.20 | N/A | N/A | $203.59 M |
| 03/31/2021 | Q1 2021 | N/A | -$0.00 | N/A | N/A | $181.31 M |
| 12/31/2020 | Q4 2020 | N/A | $0.16 | N/A | N/A | $188.54 M |
| 09/30/2020 | Q3 2020 | N/A | -$0.05 | N/A | N/A | $181.67 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Guardian Pharmacy Services, Inc. Earnings: FAQ's
Guardian Pharmacy Services, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 10th, 2025 based offlast year's report dates.
In the previous quarter, Guardian Pharmacy Services, Inc. (:GRDN) reported $0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $0.24 by $0.01.
The conference call for Guardian Pharmacy Services, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Guardian Pharmacy Services, Inc.'s latest earnings report can be read online.
Guardian Pharmacy Services, Inc. (:GRDN) has a recorded annual revenue of $1.23 B.
Guardian Pharmacy Services, Inc. (:GRDN) has a recorded net income of $-87,287,000.Guardian Pharmacy Services, Inc. has generated $-1.77 earnings per share over the last four quarters.
Guardian Pharmacy Services, Inc. (:GRDN) has a price-to-earnings ratio of 45.27 and price/earnings-to-growth ratio is 0.31.